Cross-walk of the Chronic Liver Disease Questionnaire for Nonalcoholic Steatohepatitis (CLDQ-NASH) and the EuroQol EQ-5D-5L in patients with NASH
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cross-walk of the Chronic Liver Disease Questionnaire for Nonalcoholic Steatohepatitis (CLDQ-NASH) and the EuroQol EQ-5D-5L in patients with NASH
Authors
Keywords
-
Journal
Health and Quality of Life Outcomes
Volume 21, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-10-14
DOI
10.1186/s12955-023-02195-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Trends in obesity prevalence and cardiometabolic risk factor control in US adults with diabetes, 1999–2020
- (2023) Gang Hu et al. Obesity
- The Association Between Obesity and the 5-Year Prevalence of Morbidity and Mortality Among Adults with Type 2 Diabetes
- (2023) Kristina S. Boye et al. Diabetes Therapy
- Current therapies and new developments in NASH
- (2022) Jean-François Dufour et al. GUT
- The Economic Burden of Non-Alcoholic Steatohepatitis: A Systematic Review
- (2022) Michal Witkowski et al. PHARMACOECONOMICS
- The epidemiology of non-alcoholic steatohepatitis (NASH) in the United States between 2010-2020: a population-based study
- (2022) Osama Hamid et al. Annals of Hepatology
- Type 2 diabetes
- (2022) Ehtasham Ahmad et al. LANCET
- Cross-walk of the Assessment of Spondyloarthritis International Society Health Index and Ankylosing Spondylitis Quality of Life Scores in Ankylosing Spondylitis and Non-radiographic Axial Spondyloarthritis Patients
- (2021) James Pike et al. Rheumatology and Therapy
- Obeticholic Acid Impact on Quality of Life in Patients With Nonalcoholic Steatohepatitis: REGENERATE 18-Month Interim Analysis
- (2021) Zobair M. Younossi et al. Clinical Gastroenterology and Hepatology
- IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045
- (2021) Hong Sun et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- US population norms for the EQ-5D-5L and comparison of norms from face-to-face and online samples
- (2020) Ruixuan Jiang et al. QUALITY OF LIFE RESEARCH
- Validation of Chronic Liver Disease Questionnaire for Non-Alcoholic Steatohepatitis in Patients with Biopsy-Proven Non-alcoholic Steatohepatitis
- (2019) Zobair M. Younossi et al. Clinical Gastroenterology and Hepatology
- Reduced Patient-Reported Outcome Scores Associate with Level of Fibrosis in Patients with Nonalcoholic Steatohepatitis
- (2019) Zobair M. Younossi et al. Clinical Gastroenterology and Hepatology
- From NASH to HCC: current concepts and future challenges
- (2019) Quentin M. Anstee et al. Nature Reviews Gastroenterology & Hepatology
- United States Valuation of EQ-5D-5L Health States Using an International Protocol
- (2019) A. Simon Pickard et al. VALUE IN HEALTH
- Review and critical appraisal of studies mapping from quality of life or clinical measures to EQ-5D: an online database and application of the MAPS statement
- (2018) Helen Dakin et al. Health and Quality of Life Outcomes
- Minimally Important Difference of the EQ-5D-5L Index Score in Adults with Type 2 Diabetes
- (2018) Nathan S. McClure et al. VALUE IN HEALTH
- Health-related Quality of Life in Non-alcoholic Fatty Liver Disease Associates With Hepatic Inflammation
- (2018) Yvonne Huber et al. Clinical Gastroenterology and Hepatology
- Mapping to Estimate Health-State Utility from Non–Preference-Based Outcome Measures: An ISPOR Good Practices for Outcomes Research Task Force Report
- (2017) Allan J. Wailoo et al. VALUE IN HEALTH
- Prevalence and recognition of obesity and its associated comorbidities: cross-sectional analysis of electronic health record data from a large US integrated health system
- (2017) Kevin M Pantalone et al. BMJ Open
- Prevalence and co-prevalence of comorbidities among patients with type 2 diabetes mellitus
- (2016) Kristy Iglay et al. CURRENT MEDICAL RESEARCH AND OPINION
- Evidence for validity of a national physician and patient-reported, cross-sectional survey in China and UK: the Disease Specific Programme
- (2016) S M Babineaux et al. BMJ Open
- Trends in medication use in patients with type 2 diabetes mellitus: a long-term view of real-world treatment between 2000 and 2015
- (2016) Victoria Higgins et al. Diabetes Metabolic Syndrome and Obesity-Targets and Therapy
- The MAPS Reporting Statement for Studies Mapping onto Generic Preference-Based Outcome Measures: Explanation and Elaboration
- (2015) Stavros Petrou et al. PHARMACOECONOMICS
- Comparing the EQ-5D 3L and 5L: measurement properties and association with chronic conditions and multimorbidity in the general population
- (2014) Calypse B Agborsangaya et al. Health and Quality of Life Outcomes
- Use of generic and condition-specific measures of health-related quality of life in NICE decision-making: a systematic review, statistical modelling and survey
- (2014) Louise Longworth et al. HEALTH TECHNOLOGY ASSESSMENT
- Mapping EQ-5D Utility Scores from the Incontinence Quality of Life Questionnaire among Patients with Neurogenic and Idiopathic Overactive Bladder
- (2013) Stephen Kay et al. VALUE IN HEALTH
- Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults
- (2011) G. Vernon et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Relationship Between Obesity and Diabetes in a US Adult Population: Findings from the National Health and Nutrition Examination Survey, 1999–2006
- (2010) Ninh T. Nguyen et al. OBESITY SURGERY
- Quality of life in adults with nonalcoholic fatty liver disease: Baseline data from the nonalcoholic steatohepatitis clinical research network
- (2009) Kristin David et al. HEPATOLOGY
- Real-world physician and patient behaviour across countries: Disease-Specific Programmes – a means to understand
- (2008) P. Anderson et al. CURRENT MEDICAL RESEARCH AND OPINION
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started